

SVP, Chief Financial Officer
Mike Fedock is IQVIA’s chief financial officer, responsible for IQVIA’s controllers, FP&A, treasury, tax and internal audit.
In his previous role, Mike served as senior vice president of the Corporate Financial Planning & Analysis function for IQVIA. Prior to this, he served as the chief financial officer of the R&D Solutions business. Mike has over 25 years’ experience in the contract research organization and healthcare sectors.
Before joining IQVIA, Mike was the chief financial officer for Q2 Solutions (now IQVIA Laboratories), the joint venture between IQVIA and Quest Diagnostics. Earlier in his career, Mike spent 13 years at ICON Clinical Research where he held various positions of increasing responsibilities serving in both divisional chief financial officer and operational leadership positions. Mike has also worked for GloboMax LLC (sold to ICON in 2003), NovaScreen Biosciences (a Perkin Elmer company), performed research at GlaxoSmithKline and Sanofi, and worked in the traumatic brain injury unit at Einstein Hospital in Philadelphia.
Mike has a bachelor’s degree in biological sciences from Drexel University and a Master of Business Administration from the University of Baltimore.